Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Chicago › NPI 1053085373
Lab

Being Human Medical INC

Being Human Medical INC was paid $1.71M by Medicaid between Mar 2022 and May 2023, across 8 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 27% of everything it billed.

33Billing provider infoBEING HUMAN MEDICAL INC
CHICAGO, IL 60646
33aNPI1053085373assigned 08/02/2021
28Total paid$1.71M
24GClaims33,366
24DCodes billed8
24AFirst – last monthMar 2022 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#64 of 235
Median peer was paid$123K
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20226,382$230K
202326,984$1.48M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 27% 6,609 2,131 $471K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 24% 2,993 689 $414K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 16% 7,236 2,315 $280K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 11% 1,501 371 $194K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 10% 8,094 2,192 $177K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 8.5% 6,260 2,311 $145K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.9% 624 158 $32K
87400 <1% 49 42 $280.59

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMAMTANI, ANOOP (CEO)